Generic Competition And Pricing Pressures Hold Back AstraZeneca In The First Quarter
This article was originally published in The Pink Sheet Daily
Executive Summary
AstraZeneca reports declines in revenues and operating profits in the 2011 first quarter, but expects its earnings per share will be boosted this year from tax and patent settlements.